{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T17:10:34Z","timestamp":1790788234780,"version":"4.1.0"},"reference-count":63,"publisher":"MDPI AG","issue":"1","license":[{"start":{"date-parts":[[2020,2,17]],"date-time":"2020-02-17T00:00:00Z","timestamp":1581897600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"German Center for Infections Research","award":["DZIF-TTU07.803"],"award-info":[{"award-number":["DZIF-TTU07.803"]}]},{"name":"German Center for Infections Research","award":["DZIF-TTU07.805"],"award-info":[{"award-number":["DZIF-TTU07.805"]}]},{"name":"German Research Council","award":["DFG\/SFB738 Project A6"],"award-info":[{"award-number":["DFG\/SFB738 Project A6"]}]},{"name":"German Research Council","award":["DFG\/REBIRTH Unit 6.4"],"award-info":[{"award-number":["DFG\/REBIRTH Unit 6.4"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Vaccines"],"abstract":"<jats:p>Human cytomegalovirus (HCMV or HHV-5) is a globally spread pathogen with strictly human tropism that establishes a life-long persistence. After primary infection, high levels of long-term T and B cell responses are elicited, but the virus is not cleared. HCMV persists mainly in hematopoietic reservoirs, whereby occasional viral reactivation and spread are well controlled in immunocompetent hosts. However, when the immune system cannot control viral infections or reactivations, such as with newborns, patients with immune deficiencies, or immune-compromised patients after transplantations, the lytic outbursts can be severely debilitating or lethal. The development of vaccines for immunization of immune-compromised hosts has been challenging. Several vaccine candidates did not reach the potency expected in clinical trials and were not approved. Before anti-HCMV vaccines can be tested pre-clinically in immune-compromised hosts, reliable in vivo models recapitulating HCMV infection might accelerate their clinical translation. Therefore, immune-deficient mouse strains implanted with human cells and tissues and developing a human immune system (HIS) are being explored to test anti-HCMV vaccines. HIS-mice resemble immune-compromised hosts as they are equipped with antiviral human T and B cells, but the immune reactivity is overall low. Several groups have independently shown that HCMV infections and reactivations can be mirrored in HIS mice. However, these models and the analyses employed varied widely. The path forward is to improve human immune reconstitution and standardize the analyses of adaptive responses so that HIS models can be forthrightly used for testing novel generations of anti-HCMV vaccines in the preclinical pipeline.<\/jats:p>","DOI":"10.3390\/vaccines8010089","type":"journal-article","created":{"date-parts":[[2020,2,19]],"date-time":"2020-02-19T04:06:01Z","timestamp":1582085161000},"page":"89","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":18,"title":["Modeling Human Cytomegalovirus in Humanized Mice for Vaccine Testing"],"prefix":"10.3390","volume":"8","author":[{"given":"Johannes","family":"Koenig","sequence":"first","affiliation":[{"name":"Laboratory of Regenerative Immune Therapies Applied, Excellence Cluster REBIRTH, Hannover Medical School, 30625 Hannover, Germany"},{"name":"Clinic of Hematology, Hemostasis, Oncology and Stem Cell Transplantation, Hannover Medical School, 30625 Hannover, Germany"},{"name":"German Center for Infection Research (DZIF), Partner Site Hannover-Braunschweig, 30625 Hannover, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sebastian J.","family":"Theobald","sequence":"additional","affiliation":[{"name":"Laboratory of Regenerative Immune Therapies Applied, Excellence Cluster REBIRTH, Hannover Medical School, 30625 Hannover, Germany"},{"name":"Clinic of Hematology, Hemostasis, Oncology and Stem Cell Transplantation, Hannover Medical School, 30625 Hannover, Germany"},{"name":"German Center for Infection Research (DZIF), Partner Site Hannover-Braunschweig, 30625 Hannover, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Renata","family":"Stripecke","sequence":"additional","affiliation":[{"name":"Laboratory of Regenerative Immune Therapies Applied, Excellence Cluster REBIRTH, Hannover Medical School, 30625 Hannover, Germany"},{"name":"Clinic of Hematology, Hemostasis, Oncology and Stem Cell Transplantation, Hannover Medical School, 30625 Hannover, Germany"},{"name":"German Center for Infection Research (DZIF), Partner Site Hannover-Braunschweig, 30625 Hannover, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2020,2,17]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"e2034","DOI":"10.1002\/rmv.2034","article-title":"Estimation of the worldwide seroprevalence of cytomegalovirus: A systematic review and meta-analysis","volume":"29","author":"Zuhair","year":"2019","journal-title":"Rev. Med. Virol."},{"key":"ref_2","doi-asserted-by":"crossref","unstructured":"Britt, W.J. (2017). Congenital human cytomegalovirus infection and the enigma of maternal immunity. J. Virol., 91.","DOI":"10.1128\/JVI.02392-16"},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1002\/path.4437","article-title":"The pathogenesis of human cytomegalovirus","volume":"235","author":"Griffiths","year":"2015","journal-title":"J. Pathol."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.coviro.2019.08.003","article-title":"Cytomegalovirus is a tumor-associated virus: Armed and dangerous","volume":"39","author":"Cobbs","year":"2019","journal-title":"Curr. Opin. Virol."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1007\/s00430-007-0040-7","article-title":"Incidental discovery of high systemic lupus erythematosus disease activity associated with cytomegalovirus viral activity","volume":"196","author":"Su","year":"2007","journal-title":"Med. Microbiol. Immunol."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1016\/S0966-842X(03)00149-5","article-title":"Models of hcmv latency and reactivation","volume":"11","author":"Streblow","year":"2003","journal-title":"Trends Microbiol."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1016\/j.jcv.2007.11.014","article-title":"Human cytomegalovirus: Latency and reactivation in the myeloid lineage","volume":"41","author":"Sinclair","year":"2008","journal-title":"J. Clin. Virol."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"3835","DOI":"10.1182\/blood-2015-03-631853","article-title":"Cmv reactivation drives posttransplant t-cell reconstitution and results in defects in the underlying tcrbeta repertoire","volume":"125","author":"Suessmuth","year":"2015","journal-title":"Blood"},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"2254","DOI":"10.1111\/ajt.13791","article-title":"The cell biology of cytomegalovirus: Implications for transplantation","volume":"16","author":"Kaminski","year":"2016","journal-title":"Am. J. Transplant"},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"9109","DOI":"10.1128\/JVI.00827-07","article-title":"Human cytomegalovirus gene expression is silenced by daxx-mediated intrinsic immune defense in model latent infections established in vitro","volume":"81","author":"Saffert","year":"2007","journal-title":"J. Virol."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"1186","DOI":"10.3389\/fmicb.2019.01186","article-title":"Human cytomegalovirus latency and reactivation in allogeneic hematopoietic stem cell transplant recipients","volume":"10","author":"Stern","year":"2019","journal-title":"Front. Microbiol."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1093\/cid\/ciu364","article-title":"Donor cytomegalovirus status influences the outcome of allogeneic stem cell transplant: A study by the european group for blood and marrow transplantation","volume":"59","author":"Ljungman","year":"2014","journal-title":"Clin. Infect Dis."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1111\/j.1399-3062.2010.00504.x","article-title":"Pre-transplant cytomegalovirus (cmv) serostatus remains the most important determinant of cmv reactivation after allogeneic hematopoietic stem cell transplantation in the era of surveillance and preemptive therapy","volume":"12","author":"George","year":"2010","journal-title":"Transpl. Infect Dis."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1038\/bmt.2008.162","article-title":"Management of cmv, hhv-6, hhv-7 and kaposi-sarcoma herpesvirus (hhv-8) infections in patients with hematological malignancies and after sct","volume":"42","author":"Ljungman","year":"2008","journal-title":"Bone Marrow Transplant"},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"2433","DOI":"10.1056\/NEJMoa1706640","article-title":"Letermovir prophylaxis for cytomegalovirus in hematopoietic-cell transplantation","volume":"377","author":"Marty","year":"2017","journal-title":"N. Engl. J. Med."},{"key":"ref_16","doi-asserted-by":"crossref","unstructured":"Ljungman, P., Schmitt, M., Marty, F.M., Maertens, J., Chemaly, R.F., Kartsonis, N.A., Butterton, J.R., Wan, H., Teal, V.L., and Sarratt, K. (2019). A mortality analysis of letermovir prophylaxis for cytomegalovirus (cmv) in cmv-seropositive recipients of allogeneic hematopoietic-cell transplantation. Clin. Infect Dis.","DOI":"10.1093\/cid\/ciz490"},{"key":"ref_17","doi-asserted-by":"crossref","unstructured":"Schleiss, M.R., Permar, S.R., and Plotkin, S.A. (2017). Progress toward development of a vaccine against congenital cytomegalovirus infection. Clin. Vaccine Immunol., 24.","DOI":"10.1128\/CVI.00268-17"},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"1256","DOI":"10.1016\/S0140-6736(11)60136-0","article-title":"Cytomegalovirus glycoprotein-b vaccine with mf59 adjuvant in transplant recipients: A phase 2 randomised placebo-controlled trial","volume":"377","author":"Griffiths","year":"2011","journal-title":"Lancet"},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1016\/S1473-3099(11)70344-9","article-title":"A novel therapeutic cytomegalovirus DNA vaccine in allogeneic haemopoietic stem-cell transplantation: A randomised, double-blind, placebo-controlled, phase 2 trial","volume":"12","author":"Boeckh","year":"2012","journal-title":"Lancet Infect Dis."},{"key":"ref_20","doi-asserted-by":"crossref","unstructured":"Reddehase, M.J., and Lemmermann, N.A.W. (2018). Mouse model of cytomegalovirus disease and immunotherapy in the immunocompromised host: Predictions for medical translation that survived the \u201ctest of time\u201d. Viruses, 10.","DOI":"10.3390\/v10120693"},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"1698","DOI":"10.1096\/fj.13-244178","article-title":"Protective mcmv immunity by vaccination of the salivary gland via wharton's duct: Replication-deficient recombinant adenovirus expressing individual mcmv genes elicits protection similar to that of mcmv","volume":"28","author":"Liu","year":"2014","journal-title":"FASEB J."},{"key":"ref_22","doi-asserted-by":"crossref","unstructured":"Wang, H., Huang, C., Dong, J., Yao, Y., Xie, Z., Liu, X., Zhang, W., Fang, F., and Chen, Z. (2015). Complete protection of mice against lethal murine cytomegalovirus challenge by immunization with DNA vaccines encoding envelope glycoprotein complex iii antigens gh, gl and go. PLoS ONE, 10.","DOI":"10.1371\/journal.pone.0119964"},{"key":"ref_23","doi-asserted-by":"crossref","unstructured":"Wang, H., Yao, Y., Huang, C., Fu, X., Chen, Q., Zhang, H., Chen, J., Fang, F., Xie, Z., and Chen, Z. (2014). An adjuvanted inactivated murine cytomegalovirus (mcmv) vaccine induces potent and long-term protective immunity against a lethal challenge with virulent mcmv. BMC Infect Dis., 14.","DOI":"10.1186\/1471-2334-14-195"},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1186\/1743-422X-11-104","article-title":"Comparison of multiple DNA vaccines for protection against cytomegalovirus infection in balb\/c mice","volume":"11","author":"Huang","year":"2014","journal-title":"Virol. J."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1016\/j.coviro.2017.08.005","article-title":"Rhesus monkeys for a nonhuman primate model of cytomegalovirus infections","volume":"25","author":"Itell","year":"2017","journal-title":"Curr. Opin. Virol."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"1322","DOI":"10.1128\/JVI.01669-12","article-title":"A vaccine based on the rhesus cytomegalovirus ul128 complex induces broadly neutralizing antibodies in rhesus macaques","volume":"87","author":"Wussow","year":"2013","journal-title":"J. Virol."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1016\/j.vaccine.2018.08.043","article-title":"Comparison of vaccination with rhesus cmv (rhcmv) soluble gb with a rhcmv replication-defective virus deleted for mhc class i immune evasion genes in a rhcmv challenge model","volume":"37","author":"Valencia","year":"2019","journal-title":"Vaccine"},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"13036","DOI":"10.1073\/pnas.1903317116","article-title":"Neutralization of rhesus cytomegalovirus il-10 reduces horizontal transmission and alters long-term immunity","volume":"116","author":"Deere","year":"2019","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_29","unstructured":"Davison, A.J.H.M., Dolan, A., Dargan, D.J., Gatherer, D., and Hayward, G.S. (2013). Comparative Genomics of Primate Cytomegaloviruses, Caister Academic Press."},{"key":"ref_30","unstructured":"Redwood, A.J., Shellam, G., and Smith, L.M. (2013). Molecular Evolution of Murine Cytomegalovirus Genomes, Caister Academic Press."},{"key":"ref_31","doi-asserted-by":"crossref","unstructured":"Chiuppesi, F., Nguyen, J., Park, S., Contreras, H., Kha, M., Meng, Z., Kaltcheva, T., Iniguez, A., Martinez, J., and La Rosa, C. (2018). Multiantigenic modified vaccinia virus ankara vaccine vectors to elicit potent humoral and cellular immune reponses against human cytomegalovirus in mice. J. Virol., 92.","DOI":"10.1128\/JVI.01012-18"},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"17965","DOI":"10.1073\/pnas.1415310111","article-title":"Antibody-driven design of a human cytomegalovirus ghglpul128l subunit vaccine that selectively elicits potent neutralizing antibodies","volume":"111","author":"Kabanova","year":"2014","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_33","doi-asserted-by":"crossref","unstructured":"Lehmann, C., Falk, J.J., Buscher, N., Penner, I., Zimmermann, C., Gogesch, P., Sinzger, C., and Plachter, B. (2019). Dense bodies of a gh\/gl\/ul128\/ul130\/ul131 pentamer-repaired towne strain of human cytomegalovirus induce an enhanced neutralizing antibody response. J. Virol., 93.","DOI":"10.1128\/JVI.00931-19"},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1016\/j.vaccine.2012.12.009","article-title":"Vectored co-delivery of human cytomegalovirus gh and gl proteins elicits potent complement-independent neutralizing antibodies","volume":"31","author":"Loomis","year":"2013","journal-title":"Vaccine"},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"10133","DOI":"10.1128\/JVI.00463-16","article-title":"Production of cytomegalovirus dense bodies by scalable bioprocess methods maintains immunogenicity and improves neutralizing antibody titers","volume":"90","author":"Cayatte","year":"2016","journal-title":"J. Virol."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1182\/blood-2016-07-729756","article-title":"Mva vaccine encoding cmv antigens safely induces durable expansion of cmv-specific t cells in healthy adults","volume":"129","author":"Longmate","year":"2017","journal-title":"Blood"},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1016\/j.chom.2010.08.001","article-title":"Granulocyte-colony stimulating factor reactivates human cytomegalovirus in a latently infected humanized mouse model","volume":"8","author":"Smith","year":"2010","journal-title":"Cell Host Microbe"},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"2734","DOI":"10.3389\/fimmu.2018.02734","article-title":"Signatures of t and b cell development, functional responses and pd-1 upregulation after hcmv latent infections and reactivations in nod.Rag.Gamma mice humanized with cord blood cd34 (+) cells","volume":"9","author":"Theobald","year":"2018","journal-title":"Front. Immunol."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1016\/j.bbmt.2013.10.019","article-title":"Hcmv infection of humanized mice after transplantation of g-csf-mobilized peripheral blood stem cells from hcmv-seropositive donors","volume":"20","author":"Hakki","year":"2014","journal-title":"Biol. Blood Marrow Transplant"},{"key":"ref_40","doi-asserted-by":"crossref","unstructured":"Tomic, A., Varanasi, P.R., Golemac, M., Malic, S., Riese, P., Borst, E.M., Mischak-Weissinger, E., Guzman, C.A., Krmpotic, A., and Jonjic, S. (2016). Activation of innate and adaptive immunity by a recombinant human cytomegalovirus strain expressing an nkg2d ligand. PLoS Pathog., 12.","DOI":"10.1371\/journal.ppat.1006015"},{"key":"ref_41","doi-asserted-by":"crossref","unstructured":"Greenblatt, M.B., Vrbanac, V., Tivey, T., Tsang, K., Tager, A.M., and Aliprantis, A.O. (2012). Graft versus host disease in the bone marrow, liver and thymus humanized mouse model. PLoS ONE, 7.","DOI":"10.1371\/journal.pone.0044664"},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1038\/s41598-017-01051-5","article-title":"Human cytomegalovirus induces cellular and humoral virus-specific immune responses in humanized blt mice","volume":"7","author":"Crawford","year":"2017","journal-title":"Sci. Rep."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1073\/pnas.90.1.104","article-title":"Human cytomegalovirus in a scid-hu mouse: Thymic epithelial cells are prominent targets of viral replication","volume":"90","author":"Mocarski","year":"1993","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"1163","DOI":"10.1038\/s41587-019-0225-9","article-title":"Precision mouse models with expanded tropism for human pathogens","volume":"37","author":"Wahl","year":"2019","journal-title":"Nat. Biotechnol."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1146\/annurev-pathol-052016-100332","article-title":"Humanized mouse models of clinical disease","volume":"12","author":"Walsh","year":"2017","journal-title":"Annu. Rev. Pathol."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1038\/301527a0","article-title":"A severe combined immunodeficiency mutation in the mouse","volume":"301","author":"Bosma","year":"1983","journal-title":"Nature"},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"1313","DOI":"10.1038\/ni1527","article-title":"Polymorphism in sirpa modulates engraftment of human hematopoietic stem cells","volume":"8","author":"Takenaka","year":"2007","journal-title":"Nat. Immunol."},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"786","DOI":"10.1038\/nri3311","article-title":"Humanized mice for immune system investigation: Progress, promise and challenges","volume":"12","author":"Shultz","year":"2012","journal-title":"Nat. Rev. Immunol."},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"1465","DOI":"10.3727\/096368910X314161","article-title":"The assessment of human erythroid output in nod\/scid mice reconstituted with human hematopoietic stem cells","volume":"19","author":"Hayakawa","year":"2010","journal-title":"Cell Transplant"},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1016\/0092-8674(92)90030-G","article-title":"Rag-1-deficient mice have no mature b and t lymphocytes","volume":"68","author":"Mombaerts","year":"1992","journal-title":"Cell"},{"key":"ref_51","doi-asserted-by":"crossref","unstructured":"Shultz, L.D., Keck, J., Burzenski, L., Jangalwe, S., Vaidya, S., Greiner, D.L., and Brehm, M.A. (2019). Humanized mouse models of immunological diseases and precision medicine. Mamm. Genome.","DOI":"10.1007\/s00335-019-09796-2"},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1016\/j.jviromet.2016.06.008","article-title":"Generation of a gaussia luciferase-expressing endotheliotropic cytomegalovirus for screening approaches and mutant analyses","volume":"235","author":"Falk","year":"2016","journal-title":"J. Virol. Methods"},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"S125","DOI":"10.1093\/infdis\/jit319","article-title":"Overcoming current limitations in humanized mouse research","volume":"208","author":"Brehm","year":"2013","journal-title":"J. Infect Dis."},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"3076","DOI":"10.1182\/blood-2010-08-301507","article-title":"Development of human cd4+ foxp3+ regulatory t cells in human stem cell factor-, granulocyte-macrophage colony-stimulating factor-, and interleukin-3-expressing nod-scid il2rgamma(null) humanized mice","volume":"117","author":"Billerbeck","year":"2011","journal-title":"Blood"},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"1351","DOI":"10.1038\/nm.4202","article-title":"Microenvironment-dependent growth of preneoplastic and malignant plasma cells in humanized mice","volume":"22","author":"Das","year":"2016","journal-title":"Nat. Med."},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"959","DOI":"10.1182\/blood-2016-04-709584","article-title":"A novel humanized mouse model with significant improvement of class-switched, antigen-specific antibody production","volume":"129","author":"Yu","year":"2017","journal-title":"Blood"},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1080\/21645515.2017.1403703","article-title":"Generation and testing anti-influenza human monoclonal antibodies in a new humanized mouse model (draga: Hla-a2. Hla-dr4. Rag1 ko. Il-2rgammac ko. Nod)","volume":"14","author":"Mendoza","year":"2018","journal-title":"Hum. Vaccin. Immunother."},{"key":"ref_58","doi-asserted-by":"crossref","unstructured":"Danner, R., Chaudhari, S.N., Rosenberger, J., Surls, J., Richie, T.L., Brumeanu, T.D., and Casares, S. (2011). Expression of hla class ii molecules in humanized nod.Rag1ko.Il2rgcko mice is critical for development and function of human t and b cells. PLoS ONE, 6.","DOI":"10.1371\/journal.pone.0019826"},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"14060","DOI":"10.1038\/mtm.2014.60","article-title":"Engineered dendritic cells from cord blood and adult blood accelerate effector t cell immune reconstitution against hcmv","volume":"1","author":"Daenthanasanmak","year":"2015","journal-title":"Mol. Ther. Methods Clin. Dev."},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"4636","DOI":"10.4049\/jimmunol.1302887","article-title":"Dendritic cell-mediated immune humanization of mice: Implications for allogeneic and xenogeneic stem cell transplantation","volume":"192","author":"Salguero","year":"2014","journal-title":"J. Immunol."},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"1709","DOI":"10.3389\/fimmu.2017.01709","article-title":"Multidimensional analysis integrating human t-cell signatures in lymphatic tissues with sex of humanized mice for prediction of responses after dendritic cell immunization","volume":"8","author":"Volk","year":"2017","journal-title":"Front. Immunol."},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1080\/14760584.2018.1526085","article-title":"A fifty-year odyssey: Prospects for a cytomegalovirus vaccine in transplant and congenital infection","volume":"17","author":"Diamond","year":"2018","journal-title":"Expert Rev. Vaccine"},{"key":"ref_63","doi-asserted-by":"crossref","unstructured":"Gogesch, P., Penner, I., Krauter, S., Buscher, N., Grode, L., Aydin, I., and Plachter, B. (2019). Production strategies for pentamer-positive subviral dense bodies as a safe human cytomegalovirus vaccine. Vaccines (Basel), 7.","DOI":"10.3390\/vaccines7030104"}],"container-title":["Vaccines"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2076-393X\/8\/1\/89\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T08:58:27Z","timestamp":1760173107000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2076-393X\/8\/1\/89"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,2,17]]},"references-count":63,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2020,3]]}},"alternative-id":["vaccines8010089"],"URL":"https:\/\/doi.org\/10.3390\/vaccines8010089","relation":{},"ISSN":["2076-393X"],"issn-type":[{"value":"2076-393X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,2,17]]}}}